Eli Lilly breaks ground on $3.5 billion injectable drug plant in Pennsylvania
Eli Lilly began construction of a 925,000‑sq‑ft facility in Fogelsville, Pennsylvania, slated to create 850 permanent jobs and boost U.S. capacity for next‑generation obesity treatments.